{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:21:12Z","timestamp":1787610072723,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011089","name":"University of Wisconsin Foundation","doi-asserted-by":"publisher","award":["Evan P. and Marion Helafer Professorship"],"award-info":[{"award-number":["Evan P. and Marion Helafer Professorship"]}],"id":[{"id":"10.13039\/100011089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX004921; 1I01CX002393; 1IK6BX006317"],"award-info":[{"award-number":["I01BX004921; 1I01CX002393; 1IK6BX006317"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01BX005917; I01CX002210; IK6BX006041"],"award-info":[{"award-number":["I01BX005917; I01CX002210; IK6BX006041"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007015","name":"University of Wisconsin-Madison","doi-asserted-by":"publisher","award":["Frederic E. Mohs Skin Cancer research Chair Endowment"],"award-info":[{"award-number":["Frederic E. Mohs Skin Cancer research Chair Endowment"]}],"id":[{"id":"10.13039\/100007015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA261937"],"award-info":[{"award-number":["R01CA261937"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Progression of cutaneous primary melanoma that arises from melanocytes leads to lethal metastatic disease. Molecular mechanisms that control the growth of primary melanoma in the skin and promote progression are not fully understood. Previously we showed that RAP guanine exchange factors EPAC1\/2 (Exchange Proteins Activated by cyclic AMP) promote the growth of primary melanoma and loss of dependency on EPACs is associated with metastatic progression. In this study, we show that EPACs are activated during malignant transformation of melanocytes, and chemical inhibition or genetic deletion of EPAC inhibits melanomagenesis in\n                    <jats:italic>Braf\/Pten<\/jats:italic>\n                    mice. Low expression of EPAC mRNA and its effector RAP1-GTP protein in primary melanoma correlate with better recurrence-free survival. RNAseq analysis of matched primary and metastatic melanoma cells treated with an EPAC inhibitor showed that TXNIP, an important regulator of redox homeostasis, is a downstream effector of EPAC signaling. We also show that EPACs promote melanoma growth by regulating redox homeostasis and mitochondrial ROS through activation of mechanistic target of rapamycin complex 1 (mTORC1) that stabilizes hypoxia-inducible factor 1-alpha (HIF-1\u03b1), a transcriptional activator of redox regulator TXNIP and glycolytic enzymes. Our data suggest that targeting mechanisms that melanoma cells employ to bypass EPAC dependency is a potential therapeutic approach.\n                  <\/jats:p>","DOI":"10.1038\/s41388-026-03895-6","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T10:53:57Z","timestamp":1784976837000},"page":"3702-3718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thioredoxin interacting protein (TXNIP), a redox regulator, mediates the EPAC-RAP1 signaling dependency of primary melanoma"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9386-312X","authenticated-orcid":false,"given":"Sireesh Kumar","family":"Teertam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1812-9860","authenticated-orcid":false,"given":"Mithalesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Altameemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan N.","family":"Rossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9038-878X","authenticated-orcid":false,"given":"Michael A.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-1694","authenticated-orcid":false,"given":"Xiaodong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6468-7663","authenticated-orcid":false,"given":"Vijayasaradhi","family":"Setaluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"3895_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature15726","volume":"527","author":"E Piskounova","year":"2015","unstructured":"Piskounova E, Agathocleous M, Murphy MM, Hu Z, Huddlestun SE, Zhao Z, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527:186\u201391.","journal-title":"Nature"},{"key":"3895_CR2","doi-asserted-by":"crossref","first-page":"308re308","DOI":"10.1126\/scitranslmed.aad3740","volume":"7","author":"K Le Gal","year":"2015","unstructured":"Le Gal K, Ibrahim MX, Wiel C, Sayin VI, Akula MK, Karlsson C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7:308re308.","journal-title":"Sci Transl Med"},{"key":"3895_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1152\/physrev.00025.2017","volume":"98","author":"WG Robichaux 3rd","year":"2018","unstructured":"Robichaux WG 3rd, Cheng X. Intracellular cAMP sensor EPAC: physiology, pathophysiology, and therapeutics development. Physiol Rev. 2018;98:919\u20131053.","journal-title":"Physiol Rev"},{"key":"3895_CR4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1042\/BJ20140952","volume":"465","author":"M Almahariq","year":"2015","unstructured":"Almahariq M, Mei FC, Wang H, Cao AT, Yao S, Soong L, et al. Exchange protein directly activated by cAMP modulates regulatory T-cell-mediated immunosuppression. Biochem J. 2015;465:295\u2013303.","journal-title":"Biochem J"},{"key":"3895_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/ars.2015.6485","volume":"27","author":"Z Yang","year":"2017","unstructured":"Yang Z, Kirton HM, Al-Owais M, Thireau J, Richard S, Peers C, et al. Epac2-Rap1 signaling regulates reactive oxygen species production and susceptibility to cardiac arrhythmias. Antioxid Redox Signal. 2017;27:117\u201332.","journal-title":"Antioxid Redox Signal"},{"key":"3895_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/mol.114.095158","volume":"87","author":"M Almahariq","year":"2015","unstructured":"Almahariq M, Chao C, Mei FC, Hellmich MR, Patrikeev I, Motamedi M, et al. Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo. Mol Pharmacol. 2015;87:142\u20139.","journal-title":"Mol Pharmacol"},{"key":"3895_CR7","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/1541-7786.MCR-22-0026","volume":"20","author":"A Krishnan","year":"2022","unstructured":"Krishnan A, Bhasker AI, Singh MK, Rodriguez CI, Perez EC, Altameemi S, et al. EPAC regulates melanoma growth by stimulating mTORC1 signaling and loss of EPAC signaling dependence correlates with melanoma progression. Mol Cancer Res. 2022;20:1548\u201360.","journal-title":"Mol Cancer Res"},{"key":"3895_CR8","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/1541-7786.MCR-17-0067","volume":"15","author":"CI Rodriguez","year":"2017","unstructured":"Rodriguez CI, Castro-Perez E, Prabhakar K, Block L, Longley BJ, Wisinski JA, et al. EPAC-RAP1 axis-mediated switch in the response of primary and metastatic melanoma to cyclic AMP. Mol Cancer Res. 2017;15:1792\u2013802.","journal-title":"Mol Cancer Res"},{"key":"3895_CR9","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1681\/ASN.2013070679","volume":"25","author":"G Stokman","year":"2014","unstructured":"Stokman G, Qin Y, Booij TH, Ramaiahgari S, Lacombe M, Dolman ME, et al. Epac-Rap signaling reduces oxidative stress in the tubular epithelium. J Am Soc Nephrol. 2014;25:1474\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"3895_CR10","first-page":"283","volume":"74","author":"M Herlyn","year":"1985","unstructured":"Herlyn M, Balaban G, Bennicelli J, Dt Guerry, Halaban R, Herlyn D, et al. Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst. 1985;74:283\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"3895_CR11","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/pcmr.12083","volume":"26","author":"S Devi","year":"2013","unstructured":"Devi S, Markandeya Y, Maddodi N, Dhingra A, Vardi N, Balijepalli RC, et al. Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes. Pigment Cell Melanoma Res. 2013;26:348\u201356.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3895_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1128\/MCB.01227-12","volume":"33","author":"J Yan","year":"2013","unstructured":"Yan J, Mei FC, Cheng H, Lao DH, Hu Y, Wei J, et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol Cell Biol. 2013;33:918\u201326.","journal-title":"Mol Cell Biol"},{"key":"3895_CR13","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"Dankort","year":"2009","unstructured":"Dankort, Curley D, Cartlidge DP, Nelson RA, Karnezis B, Damsky AN, et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 2009;41:544\u201352.","journal-title":"Nat Genet"},{"key":"3895_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.canlet.2017.11.027","volume":"414","author":"CI Rodriguez","year":"2018","unstructured":"Rodriguez CI, Castro-Perez E, Longley BJ, Setaluri V. Elevated cyclic AMP levels promote BRAF(CA)\/Pten(-\/-) mouse melanoma growth but pCREB is negatively correlated with human melanoma progression. Cancer Lett. 2018;414:268\u201377.","journal-title":"Cancer Lett"},{"key":"3895_CR15","first-page":"10","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. CUTADAPT removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:10\u201312.","journal-title":"EMBnetjournal"},{"key":"3895_CR16","unstructured":"Andrews S.Babraham Bioinformatics. https:\/\/www.bioinformatics.babraham.ac.uk\/index.html"},{"key":"3895_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"3895_CR18","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31:166\u20139.","journal-title":"Bioinformatics"},{"key":"3895_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"3895_CR20","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","volume":"28","author":"L Wang","year":"2012","unstructured":"Wang L, Wang S, Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics. 2012;28:2184\u20135.","journal-title":"Bioinformatics"},{"key":"3895_CR21","unstructured":"Henning C. Cran-package fpc. https:\/\/cran.r-project.org\/web\/packages\/fpc\/index.html"},{"key":"3895_CR22","unstructured":"Alexa AR, J. topGO: enrichment analysis for Gene Ontology. R package version 1.38.1, 2019."},{"key":"3895_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"3895_CR24","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3895_CR25","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"3895_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u20134.","journal-title":"Cancer Discov"},{"key":"3895_CR27","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/cdd.2016.12","volume":"23","author":"I Amelio","year":"2016","unstructured":"Amelio I, Tsvetkov PO, Knight RA, Lisitsa A, Melino G, Antonov AV. SynTarget: an online tool to test the synergetic effect of genes on survival outcome in cancer. Cell Death Differ. 2016;23:912.","journal-title":"Cell Death Differ"},{"key":"3895_CR28","doi-asserted-by":"publisher","first-page":"18613","DOI":"10.1073\/pnas.1210209109","volume":"109","author":"T Tsalkova","year":"2012","unstructured":"Tsalkova T, Mei FC, Li S, Chepurny OG, Leech CA, Liu T, et al. Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc Natl Acad Sci USA 2012;109:18613\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3895_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1124\/mol.112.080689","volume":"83","author":"M Almahariq","year":"2013","unstructured":"Almahariq M, Tsalkova T, Mei FC, Chen H, Zhou J, Sastry SK, et al. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol Pharmacol. 2013;83:122\u20138.","journal-title":"Mol Pharmacol"},{"key":"3895_CR30","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436:720\u20134.","journal-title":"Nature"},{"key":"3895_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1165\/rcmb.2008-0091TR","volume":"39","author":"CH Serezani","year":"2008","unstructured":"Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M. Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol. 2008;39:127\u201332.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3895_CR32","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"E-H Choi","year":"2023","unstructured":"Choi E-H, Park S-J. TXNIP: a key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med. 2023;55:1348\u201356.","journal-title":"Exp Mol Med"},{"key":"3895_CR33","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1038\/s41416-023-02442-4","volume":"129","author":"J Deng","year":"2023","unstructured":"Deng J, Pan T, Liu Z, McCarthy C, Vicencio JM, Cao L, et al. The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control. Br J Cancer. 2023;129:1877\u201392.","journal-title":"Br J Cancer"},{"key":"3895_CR34","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1089\/ars.2021.0038","volume":"36","author":"H Masutani","year":"2022","unstructured":"Masutani H. Thioredoxin-interacting protein in cancer and diabetes. Antioxid Redox Signal. 2022;36:1001\u201322.","journal-title":"Antioxid Redox Signal"},{"key":"3895_CR35","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1161\/CIRCRESAHA.122.321351","volume":"131","author":"Y Nakayama","year":"2022","unstructured":"Nakayama Y, Mukai N, Kreitzer G, Patwari P, Yoshioka J. Interaction of ARRDC4 With GLUT1 mediates metabolic stress in the ischemic heart. Circ Res. 2022;131:510\u201327.","journal-title":"Circ Res"},{"key":"3895_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/iub.2792","volume":"76","author":"SH Ahn","year":"2024","unstructured":"Ahn SH, Jang SK, Kim YJ, Kim G, Park KS, Park IC, et al. Amino acid deprivation induces TXNIP expression by NRF2 downregulation. IUBMB Life. 2024;76:212\u201322.","journal-title":"IUBMB Life"},{"key":"3895_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/MPA.0b013e31815929fe","volume":"36","author":"AF Baker","year":"2008","unstructured":"Baker AF, Koh MY, Williams RR, James B, Wang H, Tate WR, et al. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer. Pancreas. 2008;36:178\u201386.","journal-title":"Pancreas"},{"key":"3895_CR38","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/s44321-024-00105-2","volume":"16","author":"J Deng","year":"2024","unstructured":"Deng J, Pan T, Wang D, Hong Y, Liu Z, Zhou X, et al. The MondoA-dependent TXNIP\/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas. EMBO Mol Med. 2024;16:2080\u2013108.","journal-title":"EMBO Mol Med"},{"key":"3895_CR39","doi-asserted-by":"publisher","first-page":"23194","DOI":"10.1074\/jbc.M113.473082","volume":"288","author":"C Kibbe","year":"2013","unstructured":"Kibbe C, Chen J, Xu G, Jing G, Shalev A. FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells. J Biol Chem. 2013;288:23194\u2013202.","journal-title":"J Biol Chem"},{"key":"3895_CR40","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s11064-021-03490-z","volume":"47","author":"Q Pan","year":"2022","unstructured":"Pan Q, Ma J, Guo K. miR-223 Enhances the neuroprotection of estradiol against oxidative stress injury by inhibiting the FOXO3\/TXNIP axis. Neurochem Res. 2022;47:1865\u201377.","journal-title":"Neurochem Res"},{"key":"3895_CR41","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2014.164","volume":"34","author":"KM Dodd","year":"2015","unstructured":"Dodd KM, Yang J, Shen MH, Sampson JR, Tee AR. mTORC1 drives HIF-1alpha and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3. Oncogene. 2015;34:2239\u201350.","journal-title":"Oncogene"},{"key":"3895_CR42","doi-asserted-by":"publisher","first-page":"20534","DOI":"10.1074\/jbc.M611782200","volume":"282","author":"SC Land","year":"2007","unstructured":"Land SC, Tee AR. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem. 2007;282:20534\u201343.","journal-title":"J Biol Chem"},{"key":"3895_CR43","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"3895_CR44","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1074\/jbc.M109.034421","volume":"285","author":"G Saxena","year":"2010","unstructured":"Saxena G, Chen J, Shalev A. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. J Biol Chem. 2010;285:3997\u20134005.","journal-title":"J Biol Chem"},{"key":"3895_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15384047.2016.1250987","volume":"18","author":"SK Hong","year":"2017","unstructured":"Hong SK, Starenki D, Wu PK, Park JI. Suppression of B-Raf(V600E) melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone. Cancer Biol Ther. 2017;18:106\u201314.","journal-title":"Cancer Biol Ther"},{"key":"3895_CR46","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M210432200","volume":"278","author":"N Li","year":"2003","unstructured":"Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003;278:8516\u201325.","journal-title":"J Biol Chem"},{"key":"3895_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1210\/me.2014-1346","volume":"29","author":"S Mangmool","year":"2015","unstructured":"Mangmool S, Hemplueksa P, Parichatikanond W, Chattipakorn N. Epac is required for GLP-1R-mediated inhibition of oxidative stress and apoptosis in cardiomyocytes. Mol Endocrinol. 2015;29:583\u201396.","journal-title":"Mol Endocrinol"},{"key":"3895_CR48","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","volume":"68","author":"KS Hoek","year":"2008","unstructured":"Hoek KS, Eichhoff OM, Schlegel NC, Dobbeling U, Kobert N, Schaerer L, et al. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res. 2008;68:650\u20136.","journal-title":"Cancer Res"},{"key":"3895_CR49","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1755-148X.2011.00863.x","volume":"24","author":"E Baljinnyam","year":"2011","unstructured":"Baljinnyam E, Umemura M, De Lorenzo MS, Iwatsubo M, Chen S, Goydos JS, et al. Epac1 promotes melanoma metastasis via modification of heparan sulfate. Pigment Cell Melanoma Res. 2011;24:680\u20137.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3895_CR50","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/pcmr.12250","volume":"27","author":"E Baljinnyam","year":"2014","unstructured":"Baljinnyam E, Umemura M, Chuang C, De Lorenzo MS, Iwatsubo M, Chen S, et al. Epac1 increases migration of endothelial cells and melanoma cells via FGF2-mediated paracrine signaling. Pigment Cell Melanoma Res. 2014;27:611\u201320.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3895_CR51","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1038\/sj.bjc.6605439","volume":"101","author":"M Grandoch","year":"2009","unstructured":"Grandoch M, Rose A, ter Braak M, Jendrossek V, Rubben H, Fischer JW, et al. Epac inhibits migration and proliferation of human prostate carcinoma cells. Br J Cancer. 2009;101:2038\u201342.","journal-title":"Br J Cancer"},{"key":"3895_CR52","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3892\/or.2017.5442","volume":"37","author":"DP Sun","year":"2017","unstructured":"Sun DP, Fang CL, Chen HK, Wen KS, Hseu YC, Hung ST, et al. EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer. Oncol Rep. 2017;37:1953\u201360.","journal-title":"Oncol Rep"},{"key":"3895_CR53","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7145198","volume":"2019","author":"X Kong","year":"2019","unstructured":"Kong X, Ai G, Wang D, Chen R, Guo D, Yao Y, et al. PDE4 and Epac1 synergistically promote rectal carcinoma via the cAMP pathway. Anal Cell Pathol. 2019;2019:7145198.","journal-title":"Anal Cell Pathol"},{"key":"3895_CR54","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/thy.2017.0528","volume":"28","author":"DJ Huk","year":"2018","unstructured":"Huk DJ, Ashtekar A, Magner A, La Perle K, Kirschner LS. Deletion of Rap1b, but not Rap1a or Epac1, reduces protein kinase A-mediated thyroid cancer. Thyroid. 2018;28:1153\u201361.","journal-title":"Thyroid"},{"key":"3895_CR55","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-016-0786-0","volume":"33","author":"M Gao","year":"2016","unstructured":"Gao M, Ma Y, Bast RC Jr, Li Y, Wan L, Liu Y, et al. Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT\/Cyclin D1\/CDK4 pathway in vitro and in vivo. Med Oncol. 2016;33:73.","journal-title":"Med Oncol"},{"key":"3895_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167114","volume":"1870","author":"Z Li","year":"2024","unstructured":"Li Z, Liu Q, Cai Y, Ye N, He Z, Yao Y, et al. EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancer. Biochim Biophys Acta Mol Basis Dis. 2024;1870:167114.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3895_CR57","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.4049\/jimmunol.164.12.6287","volume":"164","author":"E Junn","year":"2000","unstructured":"Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, et al. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol. 2000;164:6287\u201395.","journal-title":"J Immunol"},{"key":"3895_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04783-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, Feng X, Yuan Y, Jiang J, Zhang P, Zhang B. Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage. Cell Death Dis. 2022;13:338.","journal-title":"Cell Death Dis"},{"key":"3895_CR59","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1158\/1078-0432.CCR-15-2380","volume":"22","author":"S Ji","year":"2016","unstructured":"Ji S, Qin Y, Liang C, Huang R, Shi S, Liu J, et al. FBW7 (F-box and WD repeat domain-containing 7) negatively regulates glucose metabolism by targeting the c-Myc\/TXNIP (thioredoxin-binding protein) axis in pancreatic cancer. Clin Cancer Res. 2016;22:3950\u201360.","journal-title":"Clin Cancer Res"},{"key":"3895_CR60","doi-asserted-by":"publisher","first-page":"5686","DOI":"10.1038\/s41388-019-0822-6","volume":"38","author":"D Jiao","year":"2019","unstructured":"Jiao D, Huan Y, Zheng J, Wei M, Zheng G, Han D, et al. UHRF1 promotes renal cell carcinoma progression through epigenetic regulation of TXNIP. Oncogene. 2019;38:5686\u201399.","journal-title":"Oncogene"},{"key":"3895_CR61","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/carcin\/bgr137","volume":"32","author":"K Nishizawa","year":"2011","unstructured":"Nishizawa K, Nishiyama H, Matsui Y, Kobayashi T, Saito R, Kotani H, et al. Thioredoxin-interacting protein suppresses bladder carcinogenesis. Carcinogenesis. 2011;32:1459\u201366.","journal-title":"Carcinogenesis"},{"key":"3895_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86329-5","volume":"11","author":"P Meylan","year":"2021","unstructured":"Meylan P, Pich C, Winkler C, Ginster S, Mury L, Sgandurra M, et al. Low expression of the PPARgamma-regulated gene thioredoxin-interacting protein accompanies human melanoma progression and promotes experimental lung metastases. Sci Rep. 2021;11:7847.","journal-title":"Sci Rep"},{"key":"3895_CR63","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.15252\/embr.201439392","volume":"15","author":"S Knoll","year":"2014","unstructured":"Knoll S, Furst K, Kowtharapu B, Schmitz U, Marquardt S, Wolkenhauer O, et al. E2F1 induces miR-224\/452 expression to drive EMT through TXNIP downregulation. EMBO Rep. 2014;15:1315\u201329.","journal-title":"EMBO Rep"},{"key":"3895_CR64","doi-asserted-by":"publisher","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","volume":"11","author":"D Talantov","year":"2005","unstructured":"Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 2005;11:7234\u201342.","journal-title":"Clin Cancer Res"},{"key":"3895_CR65","doi-asserted-by":"publisher","first-page":"e10770","DOI":"10.1371\/journal.pone.0010770","volume":"5","author":"O Kabbarah","year":"2010","unstructured":"Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE. 2010;5:e10770.","journal-title":"PLoS ONE"},{"key":"3895_CR66","first-page":"1899","volume":"16","author":"D Ortega-Bernal","year":"2018","unstructured":"Ortega-Bernal D, La Rosa CHG, Arechaga-Ocampo E, Alvarez-Avitia MA, Moreno NS, Rangel-Escareno C. A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma. Oncol Lett. 2018;16:1899\u2013911.","journal-title":"Oncol Lett"},{"key":"3895_CR67","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399\u2013408.","journal-title":"Cell"},{"key":"3895_CR68","doi-asserted-by":"crossref","unstructured":"Qannita RA, Alalami AI, Harb AA, Aleidi SM, Taneera J, Abu-Gharbieh E, et al. Targeting hypoxia-inducible factor-1 (HIF-1) in cancer: emerging therapeutic strategies and pathway regulation. Pharmaceuticals. 2024;17:195.","DOI":"10.3390\/ph17020195"},{"key":"3895_CR69","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.7314\/APJCP.2015.16.7.2953","volume":"16","author":"Y Li","year":"2015","unstructured":"Li Y, Miao LY, Xiao YL, Huang M, Yu M, Meng K, et al. Hypoxia induced high expression of thioredoxin interacting protein (TXNIP) in non-small cell lung cancer and its prognostic effect. Asian Pac J Cancer Prev. 2015;16:2953\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"key":"3895_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","volume":"4","author":"TJ Parmenter","year":"2014","unstructured":"Parmenter TJ, Kleinschmidt M, Kinross KM, Bond ST, Li J, Kaadige MR, et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov. 2014;4:423\u201333.","journal-title":"Cancer Discov"},{"key":"3895_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101838","volume":"39","author":"J Jandova","year":"2021","unstructured":"Jandova J, Wondrak GT. Genomic GLO1 deletion modulates TXNIP expression, glucose metabolism, and redox homeostasis while accelerating human A375 malignant melanoma tumor growth. Redox Biol. 2021;39:101838.","journal-title":"Redox Biol"},{"key":"3895_CR72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in cancer. Cancer Cell. 2020;38:167\u201397.","journal-title":"Cancer Cell"},{"key":"3895_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molcel.2023.11.001","volume":"84","author":"F Hecht","year":"2024","unstructured":"Hecht F, Zocchi M, Alimohammadi F, Harris IS. Regulation of antioxidants in cancer. Mol Cell. 2024;84:23\u201333.","journal-title":"Mol Cell"},{"key":"3895_CR74","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1172\/JCI85339","volume":"126","author":"M Benhar","year":"2016","unstructured":"Benhar M, Shytaj IL, Stamler JS, Savarino A. Dual targeting of the thioredoxin and glutathione systems in cancer and HIV. J Clin Investig. 2016;126:1630\u20139.","journal-title":"J Clin Investig"},{"key":"3895_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103032","volume":"70","author":"B Yang","year":"2024","unstructured":"Yang B, Lin Y, Huang Y, Shen YQ, Chen Q. Thioredoxin (Trx): a redox target and modulator of cellular senescence and aging-related diseases. Redox Biol. 2024;70:103032.","journal-title":"Redox Biol"},{"key":"3895_CR76","doi-asserted-by":"publisher","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","volume":"271","author":"LE Huang","year":"1996","unstructured":"Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 1996;271:32253\u20139.","journal-title":"J Biol Chem"},{"key":"3895_CR77","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, Zhang G, Zeng L, Zhang G, et al. SRplot: A free online platform for data visualization and graphing. PLoS ONE. 2023;18:e0294236.","journal-title":"PLoS ONE"},{"key":"3895_CR78","doi-asserted-by":"crossref","unstructured":"Li J, Miao B, Wang S, Dong W, Xu H, Si C, et al. Hiplot: a comprehensive and easy-to-use web service for boosting publication-ready biomedical data visualization. Brief Bioinform. 2022;23:bbac261.","DOI":"10.1093\/bib\/bbac261"},{"key":"3895_CR79","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","volume":"7","author":"GL Semenza","year":"2001","unstructured":"Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7:345\u201350.","journal-title":"Trends Mol Med"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03895-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03895-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:03:22Z","timestamp":1787609002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03895-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":79,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["3895"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03895-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article the e-mail address of the corresponding author Vijayasaradhi Setaluri should have been Vijayasaradhi.Setaluri@va.gov.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Animal studies were approved by the IACUC of University of Wisconsin-Madison (Protocol M006451) and VA (1594103-26). Analysis of de-identified human neonatal foreskin specimens and retrospective analyses of archived human tissue specimens were approved by UW Institutional Review Board (Protocols #2006-006 and #2016-0287).","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}